IJLSSR, VOLUME 3, ISSUE 2, MARCH 2017:920-924

Research Article (Open access)

Clinico- Histomorphological Variations in
Fibroadenoma

Somil Singhal1*, Arun. T. Miskin2, V D Dombale3, Smita Kadadavar4
1Post Graduate, Department of Pathology, SN Medical College, Karnataka, India
2Associate Professor, Department of Pathology, SN Medical College, Karnataka, India
3Professor and HOD, Department of Pathology, SN Medical College, Karnataka, India
4Assistant Professor, Department of Pathology, SN Medical College, Karnataka, India

*Address for Correspondence: Dr. Somil Singhal, Post Graduate, Department of Pathology, S. Nijalingappa Medical
College and HSK Hospital, Bagalkot, Karnataka, India

Received: 12 January 2017/Revised: 02 Feburary 2017/Accepted: 23 Feburary 2017

ABSTRACT- Introduction- Fibroadenomas are the most common benign breast tumors, which typically present as a mobile palpable breast lump. It accounts for approximately 75% of all breast lesions in young females. It can undergo a variety of histological variations, Like Apocrine metaplasia, adenosis, leaf like pattern, stromal growth and myxoid change. Therefore, this study was done to evaluate the clinico- histomorphological variations in fibroadenoma.
Materials and Methods- A retrospective study was done over a one year period from January 2015 to December 2015 at S. Nijalingappa Medical College and HSK Hospital, Bagalkot, Karnataka, India. All cases of breast lump confirmed as a fibroadenoma on histopathology were included in this study. A total of 224 cases were analyzed.
Results- The most common affected age group in the present study was 21- 30 years of age (50.45%). The majority of them presented as a unilateral lump (56.70%) and very few bilateral (4.02%). The size varies between 3-5 cms and commonly located in upper lateral quadrant (54.91%). The predominant growth pattern noted is mixed intracanalicular and pericanalicular (55.35%). The common histological changes noted were stromal overgrowth (12.05%) followed by apocrine metaplasia (9.37%) and cystic dilatation (8.92%). Rare variations such as lactational change (1.33%) and infarction (1.78%) are also noted.
Conclusion-There is numerous clinico-histomorphological variations in fibroadenoma which can be confused with other benign breast diseases. Therefore, a thorough knowledge of these changes is necessary for accurate diagnosis of fibroadenoma.
Key-words- Benign Breast Diseases (BBDs), Fibroadenoma, Histomorphological variants, Breast tumors

INTRODUCTION- Benign Breast Diseases (BBDs) is a group of breast diseases which is not cancer. It is the most common cause of breast problems in females and it is more frequent than the malignant ones [1-6]. In fact, it is at least 10 times more common than breast cancer in the west [7]. Up to 30% of the women who suffer from BBDs will require treatment at some time in their lives [8].
Fibroadenoma are the most common tumours clinically and pathologically in adolescent and women of child bearing age group; arising from the epithelium and stroma of the terminal duct-lobular unit of breast [9]. An oestrogen dependency has been suggested for the growth of fibroadenomas [10-11]. Mostly fibroadenomas present as a sharply demarcated, firm mass, usually not more than 3 cm in diameter. The cut surface is solid, grayish white, and bulging, with a whorl-like pattern and slit-like spaces [12]. In the present study, we tried to evaluate the changing pattern occurrence of fibroadenoma with a frequency of various clinico histomorphological variants.

MATERIALS AND METHODS- Lumpectomy specimens of 224 patients with clinical impression and gross features suggestive of fibroadenoma breast are included. A retrospective study is done over a one-year period from January 2015 to December 2015 at Nijalingappa Medical College and HSK Hospital, Department of Pathology, Bagalkot, Karnataka, India. All cases of breast lump confirmed as fibroadenoma on histopathology are included in this study. A total of 224 cases are analysed by paraffin embedded haematoxylin & eosin stained slides. All cases were included only female patients and were studied in details in this study.
In past year we observed in our institute that there were major differences in the occurrence of fibroadenoma and associated changes in adult age group. So we compared for various clinical (size, number, ipsilateral or bilateral presentation) and histological parameters including pattern of growth whether pericanalicular, intracanalicular or mixed; apocrine metaplasia, adenosis, epithelial hyperplasia, leaf like pattern, fibrocystic changes, stromal growth, atypical ductal hyperplasia and other changes like myxoid degeneration, hyalinization or fibrosis. The following criteria were used in the present series:

  1. Fibroadenomas were classified as pericanalicular or intracanalicular when 90% of the tumour displayed that particular type of growth pattern. If neither type could be assigned to a tumour, we diagnosed it as mixed histologic type [13].
  2. Leaf-like pattern (enhanced intracanalicular pattern) characterized by the projection of cellular stroma into clefts of cystic spaces [14].
  3. Stromal overgrowth was defined as the presence of stroma without epithelium in any low-power field (×40) [15].
  4. Epithelial hyperplasia, if present, was categorized as the usual type or atypical ductal hyperplasia according to the World Health Organization 2003 criteria [16].
OBSERVATIONS AND RESULTS- In this study, the various parameters were taken according to Age, Location, Quadrant, Size and Histological changes. Out of 224 cases, the most common age group affected were 21-30 years (50.45%) with a mean of 25.5 years. The other age groups were shown in Table 1.

Table 1: Age Distribution of Fibroadenoma

S. No. Age (Years) Total No. of Cases ( n = 224) Total percentage of Cases (n = 100 %)
1.
0 – 10 years
-
-
2.
11-20 years
57
25.45 %
3.
21-30 years
113
50.45 %
4.
31-40 years
47
20.98 %
5.
41-50 years
7
3.12 %
6.
51-60 years
-
-


Location wise distribution- 56.70% (127/224) cases were found in right breast. 88 cases (39.28%) had fibroadenoma in left breast while remaining 9 cases (4.02%) presented with bilateral fibroadenoma showed in Table 2.

Table 2: Location wise distribution

S. No. Site Total No. of Cases ( n = 224) Total percentage of Cases (n = 100 %)
1.
Left Breast
88
39.28 %
2.
Right Breast
127
56.70 %
3.
Bilateral
9
4.02 %


Quadrant wise Distribution of Fibroadenoma- 123/224 (54.91%) presented with a lump in the Upper Lateral Quadrant. Remaining 89 patients (39.73%) had a lump in Upper medial quadrant. Rest 4/224 (1.79%), 5/224 (2.23%), and 3/224 (1.34%) had a lump in lower lateral, lower medial and central respectively showed in Table 3.

Table 3: Quadrant wise Distribution of Fibroadenoma

S. No. Quadrant Total No. of Cases ( n = 224) Total percentage of Cases (n = 100 %)
1.
Upper Lateral
123
54.91 %
2.
Upper Medial
89
39.73 %
3.
Lower Lateral
4
1.79 %
4.
Lower Medial
5
2.23 %
5.
Central
3
1.34 %


Size wise Distribution in centimetres- Lumpectomy specimens showed the varying range of size (< 2 – 20 cm). Fibroadenoma of the maximum diameter of 3 – 5 cm was found in 177/224 cases (79.02 %). 31/224 (13.84 %) shows < 2 cm diameter. Remaining 16/224 cases (7.14 %) presented with a diameter of 6 – 10 cm. More than 11 cm was not found in this study showed in Table 4.

Table 4: Size wise distribution in centimetres (cm)

S. No. Size (cm) Total No. of Cases (n = 224) Total percentage of Cases (n = 100 %)
1.
< 2
31
13.84 %
2.
3 – 5
177
79.02 %
3.
6 – 10
16
7.14 %
4.
11 -20
-
-
5.
> 20
-
-


Clinico–Histological correlation:
A.Histological changes according to growth pattern-
The frequencies of various histopathologic changes observed in the sections of fibroadenomas are shown in Table 5 & 6. Of these fibroadenomas, predominant pattern of growth was mixed histologic type (Pericanalicular and intracanalicular) in 124/224 cases (55.35 %). Predominantly pericanalicular pattern was noticed in 31.70% (71/224) cases while intracanalicular in 12.95% (29/224) cases. No significant difference was observed showed in Table 5.

Table 5: Histological changes according to growth pattern

S. No. Histological changes (Predominantly Growth Pattern) Total No. of Cases ( n = 224) Total percentage of Cases (n = 100 %)
1.
Predominantly
pericanalicular
71
31.70 %
2.
Predominantly
intracanalicular
29
12.95 %
3.
Mixed (Both pericanalicular
and intracanalicular)
124
55.35 %


In this series, stromal growth 27 cases (12.05%), Apocrine metaplasia 21 cases (9.37%), and cystic dilatation 20 cases (8.92%) were common in younger females. 10 cases (4.46%) females showed atypical ductal hyperplasia and 9 cases (4.01%) showed epithelial hyperplasia. Leaf like pattern due to overt intracanalicular pattern was seen in 8 cases (3.57%). Other changes like adenosis, fibrocystic change, myxoid change, lactational change and infarction were also noted in 6 cases (2.67%), 5 cases (2.23%), 5 cases (2.23%), 3 cases (1.33%) and 4 cases (1.78%) cases respectively showed in Table 6.

Table 6. Secondary changes observed in 118 cases out of 224 cases

S. No. Histomorphological Variations Total No. of Cases ( n = 118) Total percentage of Cases (n = 52.62 %)
1.
Apocrine metaplasia
21
9.37 %
2.
Adenosis
6
2.67 %
3.
Leaf like pattern
8
3.57 %
4.
Fibrocystic change
5
2.23 %
5.
Stromal growth
27
12.05 %
6.
Epithelial hyperplasia
9
4.01%
7.
Myxoid change
5
2.23 %
8.
Atypical ductal hyperplasia
10
4.46 %
9.
Lactational change
3
1.33 %
10.
Cystic dilatation
20
8.92 %
11.
Infarction
4
1.78 %


DISCUSSION- The basic characteristic feature of all fibroadenomas is the proliferation of glandular as well as stromal elements with a sharply defined border and the pericanalicular or intracanalicular or mixed growth pattern. The enhanced intracanalicular pattern of some fibroadenomas bears a superficial resemblance to the cleft architecture of benign Phyllodes tumour and occasionally the distinction between the two tumour types may be difficult [9-12].
Fibroadenoma are stimulated by oestrogen and progesterone, pregnancy, and lactation, and they undergo atrophic changes in menopause [17-19]. This increasing rate of early presentation of fibroadenoma may be due to early or increased exposure to oestrogen, changing lifestyle. Exogenous hormone or hormonal imbalance; intake or oral contraceptive use may be underlying basic etiology. A number of factors are thought to increase chances of developing a fibroadenoma which includes dark-skinned race, high socioeconomic status, low body mass index (BMI), no or a low number of full-term pregnancies [20].
However, few studies show that higher intake of fruits and vegetables, the higher number of live births, use of oral contraceptives and moderate exercise are associated with lower frequency of fibroadenomas. [21] In the present study, 55.35% (124/224) cases were presented with predominant growth pattern of mixed histologic type. Other Histopathological features can be seen in association with fibroadenoma such as sclerosing adenosis, duct ectasia, apocrine metaplasia in 15% of cases, florid fibrocystic disease, and other features as infarction, calcification, epithelial metaplasia, and the inflammatory reaction may sometimes be present [22-24].
In this study, 27 cases (12.05%) showed stromal growth, 21 cases (9.37%) with apocrine metaplasia, 20 cases (8.92%) with cystic dilatation, 10 cases (4.46%) with atypical ductal hyperplasia, 9 cases (4.01%) with epithelial hyperplasia, 8 cases (3.57%) with leaf like pattern, 6 cases (2.67%) with adenosis, 5 cases (2.23%) of both fibrocystic change and myxoid change respectively, 4 cases (1.78%) with infarction and 3 cases (1.33%) with lactational change were noted.
It has been reported that malignant changes in fibroadenoma are found in only 0.1% of cases, usually involving the epithelial component, and the large majority are in situ lesions [23-25], while sarcomatous transformation of the stroma of fibroadenoma is believed to be an even rare phenomenon [24]. Approximately 20% of fibroadenomas have been found to have clonal chromosome aberration. [26] A lineage-restricted analysis has shown that these clonal aberrations are present in the stromal component suggesting that fibroadenoma is a benign neoplasm of the specialized stroma of the breast with an accompanying epithelial component [23,26].
Finally, this study was an attempt to explore large variety of clinico histological features of fibroadenomas, some of which are expected to be of importance in the context of management of the patient. These changes may act as predictors of the outcome of the patients. Currently there are no known identifiable characteristics to predict their unanticipated behaviour or recurrence especially in younger patients so that we can avoid the aggressive treatment or proper follow up can be instituted. However, multi institutional and larger studies should be planned for further validation.

A: Fibroadenoma showing intracanalicular
pattern (H & E X 100)


B: Fibroadenoma showing pericanalicular pattern (H & E X 100)


C: Fibroadenoma showing Leaf like Pattern (H & E X 100)


D1: Fibroadenoma showing prominent stromal growth (H & E X 40) D2: Inset shows higher magnification (H & E X 400)


E: Fibroadenoma showing infarction (H & E X 100)


CONCLUSION- The commonest fibroepithelial tumour in the female breast in the present study was fibroadenoma. A lump in the breast is the commonest presentation sometimes referred to as breast mouse. The commonest age group which is affected is the 21–30 years of age. Management of fibroadenoma may be conservative, but excision by total enucleation of the mass may be performed. Patients should undergo regular follow-up to assess complications, measure outcomes, and evaluate the need for subsequent reconstructive surgery. Throughout treatment, patients should be counselled about the benign nature of the mass, the different surgical and nonsurgical approaches, and the need for continued follow-up to determine if additional surgery is necessary. More long-term outcomes data are needed to inform treatment recommendations for adolescent patients presenting with fibroadenomas of the breast.
    REFERENCES-
  1. Khemka A, Chakravarti N, Shah S, Patel V. Palpable breast lumps: Fine needle aspiration cytology versus histopathology, a correlation of diagnostic accuracy. Internet J Surgery. 2009; 18:1.
  2. Cole P. Mark Elwood J. Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemol. 1978; 108: 112-20.
  3. Hutchinson WB, Thomas DB, Hamlin WB et al. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst. 1980; 65: 13-20.
  4. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev. 1990; 12: 228-40.
  5. Sarnelli R, Squartini F. Fibrocystic condition and “at risk” lesions in asymptomatic breasts, a morphologic study of post-menopausal women. Clin Exp. Obstet Gynecol. 1991; 18: 271-79.
  6. Cook MG, Rohan TE. The patho-epidemiology of benign proliferative epithelial disorder of the female breast. J Pathol. 1985; 146: 1-15.
  7. Mansel RE. Benign breast disease: Practitioner. 1982; 232: 830-37.
  8. Sainsbury RC. Breast In: Norman WS, Bulstrode CJK, P.Ronan O’Connel editors. Bailey and Love’s Short Practice of Surgery. 25th Ed. London: Edward Arnold Ltd. 2008; 827-35.
  9. Rosen PP. Fibroepithelial Neoplasms. In Rosen PP. Rosen?s Breast Pathology, 3 rd edition. Lippincott Williams and Wilkins 2009:187-229
  10. Bundred NJ. Aetiological factors in benign breast disease. Br J Surg 1994;81:788–9.
  11. Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathology 2006;19:599-606.
  12. Rosai J. Breast. In Rosai and Ackerman's Surgical Pathology, Vol 2, 10th Edition. Michael Houston 2011: p.1665
  13. Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 2001;115:736-742
  14. Rosen PP. Fibroepithelial Neoplasms. In Rosen PP. Rosen?s Breast Pathology, 3 rd edition. Lippincott Williams and Wilkins 2009:187-229
  15. Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer. 1986;58: 2282-2289.
  16. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumors. Pathogenesis and Genetics of Tumors of the Breast and Female Genital Tract. IARC Press: Lyon 2003.
  17. Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. J Gen Intern Med. 1998;13:640-645
  18. Levy MS, Sella T, Alweiss T, Craciun I, Libson E, Mally B. Incidence and Management of Complex Fibroadenomas. American J of Roentgenology. 2008;190: 1:214-218
  19. Abu-Rahmeh Z, Nseir W, Naroditzky I. Invasive ductal carcinoma within fibroadenoma and lung metastases. Int J Gen Med. 2012; 5: 19–21.
  20. http://www.localhealth.com/article/fibroadenoma/causes.
  21. Nelson ZC, Ray RM, Wu C, Stalsberg H, Porter P, Lampe JW et al. Fruit and Vegetable Intakes Are Associated with Lower Risk of Breast Fibroadenomas in Chinese Women. Journal of Nutrition. 2010;140:1294–1301.
  22. Tavassoli FA. Biphasic Tumors. In: Tavassoli FA, editors. Pathology of the breast. 2 nd edition. Stamford, CT: Appleton and Lange; 1999:571-623.
  23. Rosai J; Ackerman, s Surgical Pathology, 9 th edition. Mosby; 2004: 1769-831.
  24. AL-Nafussi AI, Jordan Lee B, Thomas st JJ, editors, Breast Tumors. In: Tumor Diagnosis Practical Analysis. 2nd edition. Holder Headline group. London, 2005: 165-73.
  25. Carter BA, Page DL, Schuyler P, et al. No elevation in long term breast carcinoma risk for women with fibroadenoma that contain atypical hyperplasia. Cancer 2001;92:30-36.
  26. Fletcher JA, Pinkus GS, Weinder N, et al. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 1991;138:1199-207.
International Journal of Life-Sciences Scientific Research (IJLSSR) Open Access Policy
Authors/Contributors are responsible for originality, contents, correct references, and ethical issues.
IJLSSR publishes all articles under Creative Commons Attribution- Non-Commercial 4.0 International License (CC BY-NC).
https://creativecommons.org/licenses/by-nc/4.0/legalcode

How to cite this article:
Singhal S, Miskin AT, Dombale VD, Kadadavar S: Clinico- Histomorphological variations in Fibroadenoma.
Int. J. Life. Sci. Scienti. Res.,
2017; 3(2): 920-924. DOI:10.21276/ijlssr.2017.3.2.8
Source of Financial Support: Nil, Conflict of interest: Nil